⁣Toll-like receptors, and their role in inflammation as part of innate immunity. Toll-like receptor 4 or TLR4 appears to be a very good binding partner of the spike protein. TLR4s are activated by binding to the spike protein, causing inflammation of tissues that are rich in such receptors, such as the heart. An exciting compound that prevents TLR4 activation that is mentioned is naltrexone.

Described content: TLR4 in COVID-19: https://www.hindawi.com/journals/mi/2021/8874339/
Spike and bacteria LPS binding: https://academic.oup.com/jmcb/article/12/12/916/6028992
Naltrexone: https://pubs.acs.org/doi/10.1021/acs.jcim.7b00717

**** THANK YOU VERY MUCH FOR SUPPORTING OUR CHANNEL, BY MAKING A SMALL DONATION VIA THE ABOVE THANKS BUTTON. YOU ARE THE REASON WE CAN KEEP THIS CHANNEL GOING *** "COVID-19 - Q and A for the People#11" event on ZOOM: https://merogenomics.eventbrite.ca
Holistic proactive wellbeing event: moneyminddna.ca __________________________________________________________________
Dr. Raszek Credentials: https://merogenomics.ca/en/about/ ____________________________________________________________________
Please stay in touch with us on other social media channels:
Twitter: https://twitter.com/merogenomics
Facebook: https://www.facebook.com/merogenomics/
LinkedIn: https://www.linkedin.com/company/merogenomics
Blog: https://merogenomics.ca/blog/
Newsletter Signup: http://eepurl.com/hesNGf
Instagram: https://www.instagram.com/merogenomics
Telegram : https://t.me/+FGfa8m8OkaRjOGQx
----------------------------------------
This Content Is Mirrored. Please support the original creator. All credit, royalties and sincere thanks to the original source of this video. https://www.youtube.com/watch?v=SNWAKT0KMx0 - June 24, 2022

Merogenomics | Inflammation and Toll-like receptors - C-19 Vaccines Update 48

Merogenomics, Inflammation and Toll-like receptors, C-19 Vaccines Update 48, June 24 2022